Asparaginases have been shown to suppress mTOR pathway activation, leading to reduced levels of phosphorylated 4EBP1 and a decrease in cap-dependent translation [24], and our previous work demonstrated that PegC treatment resulted in inhibition of cap-dependent translation of proteins, including MCL-1 in AML. The gene discussed is MTOR; the disease is acute myeloid leukemia.